title: The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis--what happens next? A personal viewpoint.
authors.affiliation: Department of Diabetes and Endocrinology, City Hospital, Birmingham.
authors.forename: R E J
authors.initials: RE
authors.lastname: Ryder
authors.forename: P
authors.initials: P
authors.lastname: Sen Gupta
authors.forename: K Y
authors.initials: KY
authors.lastname: Thong
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005260:Female; D006801:Humans; D054795:Incretins / Q000009:adverse effects*; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D054795:Incretins